Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Autor: Postmus, P.E., Kerr, K.M., Oudkerk, M., Senan, S., Waller, D.A., Vansteenkiste, J., Escriu, C., Peters, S.

Publikováno v: In Annals of Oncology July 2017 28 Supplement 4:iv1-iv21

MA06.06 A Phase II Trial of Ceralasertib and Durvalumab in Advanced Non-Small Cell Lung Cancer (NSCLC) with and without RAS Mutations: Results of NLMT Arm J

Autor: Middleton, G., Fletcher, P., Savage, J., Mehmi, M., Greystoke, A., Dangoor, A., Cave, J., Escriu, C., Shaw, P., Steele, N., Jain, P., Popat, S., Forster, M., Spicer, J., Coupe, N., Danson, S., Gilligan, D., Muthukumar, D., Price, G., Summers, Y., Toy, E., Billingham, L.

Publikováno v: In Journal of Thoracic Oncology November 2023 18(11) Supplement:S119-S120

1423P Clinical impact of radiological diagnosis of lymphangitic carcinomatosis in patients with extensive non-small cell lung cancer treated with immunotherapy

Autor: Bolina, A., Sallam, M., Ortega Franco, A., Wong, H., Cobben, D., Escriu, C.

Publikováno v: In Annals of Oncology October 2023 34 Supplement 2:S812-S812

A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer

Autor: Warren, A, Massie, C, Watt, K, Luko, K, Orafidiya, F, Selth, L, Mohammed, H, Chohan, B, Menon, S, Baridi, A, Zhao, W, Escriu, C, Pungsrinont, T, D'Santos, C, Yang, X, Taylor, C, Qureshi, A, Zecchini, V, Shaw, G, Dehm, S, Mills, I, Carroll, J, Tilley, W, McEwan, I, Baniahmad, A, Neal, D, Asim, M

Publikováno v: Oncogene
Warren, A Y, Massie, C E, Watt, K, Luko, K, Orafidiya, F, Selth, L A, Mohammed, H, Chohan, B S, Menon, S, Baridi, A, Zhao, W, Escriu, C, Pungsrinont, T, D'Santos, C, Yang, X, Taylor, C, Qureshi, A, Zecchini, V R, Shaw, G L, Dehm, S M, Mills, I G, Carroll, J S, Tilley, W D, McEwan, I J, Baniahmad, A, Neal, D E & Asim, M 2018, ' A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer ', Oncogene . https://doi.org/10.1038/s41388-018-0501-z, https://doi.org/10.1038/s41388-018-0501-z

Elucidation of mechanisms underlying the increased androgen receptor (AR) activity and subsequent development of aggressive prostate cancer (PrCa) is pivotal in developing new therapies. Using a systems biology approach, we interrogated the AR-regula

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a402a3b828a556f56075c971e911a047
http://europepmc.org/articles/PMC6514849

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.